PATENT CLAIM ANALYSIS

Application Number: 15895279
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "207000"]

Abstract:
Pharmaceutical compositions are provided in unit dosage forms comprising ceftolozane and tazobactam in separate unit dosage form containers, ceftolozane prepared in the absence of tazobactam, tazobactam prepared in the absence of ceftolozane, and/or compositions where ceftolozane and tazobactam are first combined within a unit dosage form container.

Claim (Index 16):
The unit dosage form package of  claim 14 , wherein the instructions recite a fixed dose combination of the ceftolozane composition and the tazobactam composition in a 2:1 ratio of the ceftolozane active to the tazobactam active and formulate the fixed dose combination for intravenous administration for the treatment of a complicated urinary tract infection.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 88.0
- Lexical Diversity: 1.82143
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15071530', '14214221', '14285185', '15844961', '14856075']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8052957432396474
- 35 USC 102 Novelty (BERT): 0.6504434113090467
- Combined Prediction Score: 0.7898105100465873
- Mean Citation Score: 540.2332100000001
- Max Citation Score: 644.7732
- Similarity Product: 576.0487636122465

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test